Cyclo Therapeutics, Inc.
6714 NW 16th Street, Suite B
Gainesville, FL 32653
December 4, 2020
VIA EDGAR
U.S. Securities and Exchange Commission
100 F Street, N.E.
Mail Stop 4628
Washington, DC 20549
Division of Corporation Finance, Office of Life Sciences
Attn: Chris Edwards
Re: | Cyclo Therapeutics, Inc. | |
| Registration Statement on Form S-1 | |
| Filed September 29, 2020, as amended | |
| File No. 333-249136 |
Dear Mr. Edwards:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Cyclo Therapeutics, Inc. hereby requests acceleration of effectiveness of the above referenced Registration Statement so that it will become effective at 4:30 p.m. EST on Monday, December 7, 2020, or as soon as thereafter practicable.
Very truly yours, | |
/s/ N. Scott Fine | |
N. Scott Fine | |
Chief Executive Officer |
cc: | Fox Rothschild LLP |
Ellenoff Grossman & Schole LLP